Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples